Cannabinoids
Best for
Cut back on cannabis
Likely strong benefit for 12 weeks · 1 study , n=128
23 papers · 18 claims · 53 outcomes scored · 13 positive
Outcomes
What cannabinoids actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Eases cravings and extends cannabis-free stretches.
Less nausea, vomiting, and appetite loss during treatment cycles.
Your stomach calms faster so queasiness stops running the show.
The background hum of worry that colors everything gets quieter.
Fewer wake-ups and more unbroken hours of real rest.
Genuine satiety replaces the constant urge to snack or overeat.
Lower intensity, fewer flares, and longer stretches of relief.
Deeper, less interrupted nights that leave you recharged by morning.
Stay more active and capable during treatment, with less pain.
Quiets the health worries and body tension that build with age.
Quiets the overthinking that hijacks execution right before you compete.
Everyday pressure stops running your nervous system hot.
Shrinks the gap between hitting the pillow and actually sleeping.
Quiets the nervous-system overdrive that keeps you wired at bedtime.
Softer stools, less straining, and more complete bowel movements.
Normalizes eating patterns thrown off by stress or low mood.
Food becomes appealing again when eating feels like a chore.
More genuine sleep hours so your body finishes its repair cycles.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Cut back on cannabis Likely strong benefit | | 1 RCT n=128 | — | 12 wk | #1/2 |
| Ease chemo stomach side effects Likely benefit | | 2 meta-analyses n=2.4k Meta-analyzed | — | 0 wk | #1/2 |
| Settle nausea and stop vomiting Faint early signal | | 3 meta-analyses n=1.5k Meta-analyzed | — | 0–6 wk | #6/15 |
| Lower day-to-day anxiety Faint early signal | | 3 meta-analyses n=1.1k Meta-analyzed | 109 mg | 1 wk | — |
| Stay asleep through the night Faint early signal | | 1 RCT n=40 | 109 mg | 1 wk | #9/15 |
| Feel full longer and crave less Faint early signal | | 1 RCT n=26 | 3.08–6.16 mg | 4 wk | #7/28 |
| Reduce everyday pain intensity Barely detectable | | 8 meta-analyses n=29k Meta-analyzed | — | 4–7 wk | — |
| Improve overall sleep quality Barely detectable | | 5 meta-analyses n=5.1k Meta-analyzed | 109 mg | 1–7 wk | — |
| Boost physical function in cancer care Not enough research | | 1 meta-analysis n=1.6k Meta-analyzed | — | 7 wk | #1/2 |
| Ease anxiety in older adults Barely detectable | | 3 meta-analyses n=1.1k Meta-analyzed | 109 mg | 1 wk | — |
| Reduce pre-competition anxiety Barely detectable | | 3 meta-analyses n=1.1k Meta-analyzed | 109 mg | 1 wk | — |
| Reduce daily stress Not enough research | | 1 RCT n=40 | 109 mg | 1 wk | — |
| Fall asleep faster Not enough research | | 1 RCT n=40 | 109 mg | 1 wk | — |
| Break the insomnia cycle Doesn't appear to help | | 2 meta-analyses n=21k Meta-analyzed | 109 mg | 1 wk | — |
| Ease constipation and stay regular Probably doesn't help | | 1 meta-analysis n=21k Meta-analyzed | — | — | — |
| Restore appetite disrupted by mood Not enough research | | 5 meta-analyses n=2.2k Meta-analyzed | 2.5–6.16 mg | 4–8 wk | — |
| Restore lost appetite Not enough research | | 5 meta-analyses n=2.2k Meta-analyzed | 2.5–6.16 mg | 4–8 wk | — |
| Sleep longer each night Not enough research | | 1 RCT n=40 | 109 mg | 1 wk | — |
Recommended Cannabinoids products
Real products that dose Cannabinoids where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.
-
LuZa Plus
Full Spectrum CBD 600 mg
Well dosed 600 mg/day A formula -
LuZa Beyond
Focus 545 mg
Well dosed 545 mg/day A formula -
LuZa Beyond
Balanced 266 mg
Well dosed 266 mg/day A formula -
LuZa Booster
CBGa 100 mg
Well dosed 100 mg/day A formula -
Green Roads
Full Spectrum CBD Softgels Original
Well dosed 25 mg/day A formula -
LuZa Broad
Broad Spectrum CBD 300 mg
Well dosed 300 mg/day A formula
Chosen for adequate Cannabinoids dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.
Risk profile
Adverse events and known drug interactions
Safety events
Sources
- 1. Systematic Review and Meta-analysis Seem to Indicate that Cannabinoids for Chronic Primary Pain Treatment Have Limited Benefit. (2022) ↑
- 2. Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia: A Randomized Double-Blind Placebo-Controlled Crossover Pilot Trial. (2025) ↑
- 3. Indications of Cannabinoids for the Palliation of Cancer-Associated Symptoms: A Systematic Review and Meta-Analysis. (2025) ↑
- 4. Systematic review and meta-analysis of cannabinoids in palliative medicine. (2018) ↑
- 5. Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study. (2022) ↑
- 6. Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis. (2023) ↑
- 7. Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis. (2019) ↑
- 8. Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis. (2022) ↑
- 9. Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial. (2025) ↑
- 10. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. (2022) ↑
Generated August 14, 2026
Related
More evidence for Cannabinoids
Ranking
Peripheral Neuropathy
NewBest Supplements to Ease Neuropathy Pain and Numbness (2026)
Evidence ranking
Apr 4, 2026
Evidence map
Peripheral Neuropathy
NewPeripheral Neuropathy: evidence map across 8 supplements
Evidence coverage map
Jul 30, 2026
Evidence map
Stress
NewStress: evidence map across 46 supplements
Evidence coverage map
Jul 30, 2026
Evidence map
Sleep
NewSleep: evidence map across 37 supplements
Evidence coverage map
Jul 30, 2026
Ingredient evidence
Ingredient evidence
New5-HTP
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewAshwagandha
All scored outcomes
Aug 14, 2026